Effect of triflumuron, a chitin synthesis inhibitor, on Aedes aegypti, Aedes albopictus and Culex quinquefasciatus under laboratory conditions
© Belinato et al.; licensee BioMed Central Ltd. 2013
Received: 9 January 2013
Accepted: 22 March 2013
Published: 4 April 2013
Resistance to traditional insecticides represents a threat to the control of disease vectors. The insect growth regulators (IGR) are a potential alternative to control mosquitoes, including resistant populations. The chitin synthesis inhibitors (CSI) are IGRs, which interfere with the insect molting process and represent one major class of compounds against Aedes aegypti populations resistant to the larvicide organophosphate temephos. In the present study, we evaluated the efficacy of the CSI triflumuron on Culex quinquefasciatus, Aedes albopictus and against several Ae. aegypti field populations.
The efficacy of triflumuron, against Cx. quinquefasciatus and Ae. albopictus was evaluated with laboratory strains through dose–response assays. Additionaly, this CSI was tested against seven Ae. aegypti field populations exhibiting distinct resistance levels to both temephos and the pyrethroid deltamethrin. Aedes aegypti populations were exposed to both a dose that inhibits 99% of the adult emergence of mosquitoes from the susceptible reference strain, Rockefeller, (EI99 = 3.95 μg/L) and the diagnostic dose (DD), corresponding to twice the EI99.
Our results indicate that triflumuron was effective in emergence inhibition (EI) of Cx. quinquefasciatus (EI50= 5.28 μg/L; EI90= 12.47 μg/L) and Ae. albopictus (EI50= 1.59 μg/L; EI90= 2.63 μg/L). Triflumuron was also effective against seven Ae. aegypti Brazilian populations resistant to both temephos and deltamethrin. Exposure of all the Ae. aegypti populations to the triflumuron EI99 of the susceptible reference strain, Rockefeller, resulted in complete inhibition of adult emergence, suggesting no cross-resistance among traditional insecticides and this CSI. However, a positive correlation between temephos resistance and tolerance to triflumuron was observed.
The results suggest that triflumuron represents a potential tool for the control of disease vectors in public health. Nevertheless, they point to the need of constant monitoring of the susceptibility status of vector populations to CSIs.
KeywordsTriflumuron Chitin synthesis inhibitors Aedes albopictus Culex quinquefasciatus Aedes aegypti Insecticide resistance
Aedes aegypti, Aedes albopictus and Culex quinquefasciatus mosquitoes are widely distributed across the globe, mainly in tropical and subtropical regions . The presence of these species is considered a public health problem, because they are involved in transmission of diseases, such as dengue, yellow fever and lymphatic filariasis [2–4].
In Latin America, the presence of these mosquitoes involves an additional risk, as they are also potential vectors of chikungunya and the West Nile virus, two arboviruses not yet reaching this continent [5–7].
Currently, organophosphates (OP) and pyrethroids (PY) still play an important role in vector control. However, their effectiveness has been hampered due to resistance [8–11]. In this sense, the use of new products is a crucial issue for the development of novel and rational control strategies [12, 13].
Compared to conventional insecticides, like OP and PY, insect growth regulators (IGRs) have distinct mechanisms of action and are more selective. Additionally, IGRs are safe for most non-target organisms, and are therefore considered as a promising alternative for insect control [12, 14]. Chitin synthesis inhibitors (CSI) are IGRs that interfere with the insect moult. CSIs belong to the benzoyl urea family, a chemical group that has been extensively studied since its discovery in the 1970s . CSI exposure results in deformities of the larval cuticle, which often become unable to survive to the next moult [15–17].
Although the CSI mechanism of action is unclear, there are several reports of its effectiveness against insects, especially in larvae [17–21]. However, since chitin is a molecule present in all life stages of insects, it is likely that a series of mosquito structures are affected as well. Wilson and Cryan, for example, verified that lufenuron affects Drosophila melanogaster eggs . Moreover, it has been shown that exposure of larvae to partially lethal doses of CSIs causes a series of disabilities in both viability and reproduction of resulting adults [23–27].
The use of CSIs has been intensified against resistant mosquito populations, given their mechanism of action is distinct from neurotoxic insecticides traditionally employed. Thus, evaluation of the efficacy of CSI on Ae. aegypti field populations is essential for rational vector control measures. In addition, the study of CSI effects on other mosquitoes could be important for the development of integrated control strategies.
Under laboratory conditions, triflumuron is effective against Ae. aegypti. When larvae are exposed to a sublethal dose, the viability of resulting adults is affected . In the present study, we evaluated the effect of this CSI in several Ae. aegypti Brazilian populations with distinct resistance levels to temephos and deltamethrin. Additionally, laboratory strains of Cx. quinquefasciatus and Ae. albopictus, two other mosquitoes of medical importance, were exposed to several triflumuron doses, and the effects on adult emergence inhibition were evaluated.
Aedes albopictus and Cx. quinquefasciatus strains were collected in Rio de Janeiro city and maintained in the laboratory for five and thirteen years, respectively. However, these laboratory strains are not considered as insecticide susceptible reference strains.
In all cases, groups of 1,000 first instar larvae were reared in plastic basins (33 × 24 × 8 cm) containing 1 L of dechlorinated water and 1 g of cat food (Friskies®, Purina, Camaquã/RS). Larvae from all species and populations were kept in a biological oxygen demand incubator (BOD) at 25 ± 1°C until the third instar, when assays were performed.
The CSI trifumuron Starycide SC 0.48® (triflumuron 48%) was provided by BayerCropscience. PESTANAL® analytical standard of temephos (97.5%) and deltamethrin (99.7%) were purchased from Sigma-Aldrich.
Dose–response bioassays were performed to evaluate triflumuron efficacy against Ae. albopictus and Cx. quinquefasciatus. Groups of 10 third instar larvae were exposed to 150 mL of triflumuron solution in transparent plastic cups. The concentrations ranged from 0.25 μg/L to 4.5 μg/L for Ae. albopictus and from 2.5 μg/L to 50 μg/L for Cx. quinquefasciatus. One milliliter of a 2.5% (w/v) solution of ground cat food (Friskies®, Purina, Camaquã/RS) was supplied once. Eight replicates were used for each concentration. Daily, mortality at each stage was checked and the resulting adults were collected [20, 26].
Aedes aegypti populations were submitted to two triflumuron doses: one corresponding to the dose inhibiting Rockefeller adult emergence at 99% (EI99) and the diagnostic dose (DD), defined as twice the EI99. For both concentrations, eight replicates were utilized under the same conditions, as described above. The EI99 and DD doses were 3.95 μg/L and 7.9 μg/L, respectively . For all populations, triflumuron assays were performed on the F2 generation; except Maceió (AL), with F3.
In contrast to the neurotoxic insecticides, triflumuron bioassays were monitored for several days, until all insects either died or reached adulthood. Adult emergence inhibition (EI) data were registered as soon as all control group specimens emerged . The results were used to calculate the EI50 and EI90 values that correspond to the triflumuron doses necessary to inhibit adult development of 50 and 90% of the specimens, respectively.
Temephos and deltamethrin bioassays to determine the resistance level of the Ae. aegypti populations
Temephos resistance was evaluated through bioassays . Groups of 20 third instar larvae were exposed to ten temephos concentrations in plastic cups with 100 ml of solution. Four replicates were used for each temephos dose.
Deltamethrin resistance was investigated with adults as described by Da-Cunha et al.. Each assay consisted of three 250 mL Wheaton bottles impregnated with the DD of this PY (5 μg/bottle), defined in this assay as the minimal amount of insecticide that kills all the specimens of a susceptible reference strain. One control bottle was impregnated only with acetone as solvent. Each bottle received 20 females, non-blood fed, one to three days old. Knock down (KD) was monitored at 15 min intervals up to 2 hours. Mosquitoes were then transferred to cages free of insecticide and mortality was registered again 24 hours later.
All the assays described here were repeated three times. The trifumuron effective doses EI50 and EI90 were calculated by probit analysis .
Since in Brazil the RR95 values are used to guide recommendations of temephos application in the field, the resistance ratios (RR) of Ae. aegypti field populations to temephos were calculated with values of the lethal concentrations that kill 95% of larvae (LC95). RRs were obtained by dividing the LC of the field populations by the equivalent LC from the Rockefeller strain.
ANOVA was adopted to compare the rate of pupae mortality among Ae. aegypti populations. Pearson’s correlation was employed to investigate the relationship between pupae mortality after exposure to triflumuron and resistance levels to temephos of Ae. aegypti field populations. The Graph-Pad Prism software version 5.0 for Windows was used to perform these analyzes (GraphPad Software, San Diego California USA, http://www.graphpad.com).
Effect of triflumuron on Ae. albopictus
Effective doses (ug/L) of triflumuron against the different mosquitoe species evaluated
Effect of triflumuron on Cx. quinquefasciatus
Effect of triflumuron, deltamethrin and temephos on Ae. aegypti field populations
Temephos and deltamethrin resistance levels in Ae. aegypti field populations
% mort DDb
In general, when field populations were exposed to triflumuron EI99, a positive correlation between temephos resistance levels and the rate of pupal mortality was found (r2 = 0,7293; p < 0,05). The same correlation was not observed when populations were exposed to DD. In contrast to temephos resistance evaluation, deltamethrin bioassays were limited to exposure to a single dose of the pyrethroid. According to this bioassay, all Ae. aegypti populations were classified as resistant to deltamethrin (Table 2). Nevertheless, there was never a correlation between deltamethrin mortality rates and pupae mortality in Ae. aegypti populations exposed to EI99 and DD of triflumuron noted.
Insecticide resistance is a growing problem that hampers mosquito control in different regions around the world. Nowadays, resistance to the main neurotoxic insecticide classes has spread among several populations of insect disease vectors. Therefore, biological control methods and the use of chemicals with distinct mechanisms of action have been increasingly employed. The utilization of chitin synthesis inhibitors, for example, represents one major current strategy for mosquito chemical control. For this reason, evaluation of the efficacy of such compounds on mosquito field populations is essential. This work deals with the CSI triflumuron efficacy against Ae. aegypti field populations, as well as laboratory colonies of Ae. albopictus and Cx. quinquefasciatus.
Our results indicate that triflumuron, under laboratory conditions, is effective against the three mosquito species evaluated. As expected, this compound induced adult emergence inhibition of Ae. albopictus and Cx. quinquefasciatus in a dose-dependent way. Previous results of our group have proven that this compound acts in a similar way on Ae. aegypti. Novaluron, another CSI, has the same effect on this mosquito . Moreover, other IGRs, such as methoprene (juvenile hormone mimic) and halofenozide (ecdysone agonist), exhibited similar results [33, 34].
Several authors have observed that high doses of CSIs caused more pronounced mortality of mosquito larvae, relative to pupae and adults [17, 18, 35]. These results corroborate the data presented here, performed with triflumuron, and confirm the direct relationship between CSI concentrations and the precocity of their effects.
Triflumuron EI50 and EI90 against Cx. quinquefasciatus (Table 1) were 3.3 and 4.7 times higher than the corresponding values in Ae. albopictus. In this latter species, in turn, triflumuron effective doses were around 1.5 - 1.8 times higher than in Ae. aegypti (EI50 and EI90 of 0.86 μg/L and 1.8 μg/L, respectively) . The triflumuron doses recommended by the manufacturer for Aedes and Culex control are around 0.12 g/L and 0.24 g/L, respectively , values much higher than the effective concentrations for these culicids.
Although there are some reports related to field simulated assays, to our knowledge this is the first evaluation of the triflumuron effect on Ae. albopictus under laboratory conditions. With respect to Cx. quinquefasciatus, our results slightly differ from other reports, which declared EI50 and EI90 values of 2.0 and 7.0 μg/L, respectively [37, 38]. Intraspecific variations of IGR effective doses among different laboratories are very common and are derived, in part, from the use of distinct protocols, as already discussed by Braga et al.. Additionally, variations in effective doses among different CSIs for a given species, or among different insect species for a given CSI, have also been reported. Diflubenzuron, the first chitin synthesis inhibitor commercially available, has been used in the control of various insect species, especially in agriculture . Concentrations of 0.5 μg/L of this compound resulted in 50% of Cx. quinquefasciatus larval mortality . Su et al. found for novaluron, another promising CSI, EI50 and EI90 of respectively 0.16 and 0.60 μg/L for Cx. quinquefasciatus. Ali et al. studied the effect of diflubenzuron in Ae. albopictus and encoutered an EI50 of 0.45 μg/L for this species, the EI90 being 0.84 μg/L . Hexaflumuron, another CSI, also proved very effective against Ae. albopictus, with the EI50 of 0.2 μg/L .
Although effective doses of triflumuron are higher when compared to other IGRs, Mian and Mulla emphasized the efficient activity of this CSI on mosquitoes, which is confirmed by its effectiveness in field trials . Sulaiman et al. verified that 14.0 mg/L of triflumuron inhibited Ae. albopictus emergence for 168 days under simulated field conditions . Likewise, Batra et al. found that triflumuron was effective against Cx. quinquefasciatus and Anopheles stephensi for seven weeks .
We also demonstrated that triflumuron is effective against Ae. aegypti field populations exhibiting different resistance levels to organophosphates and pyrethroids. In such cases, a small number of larvae always remained alive for many days, since the primary action of CSIs is not to induce mortality, but to interfere with development.
Aedes aegypti larval mortality was more pronounced when populations were treated with DD rather than EI99, confirming the direct relationship between CSI concentration and the precocity of its effects, likewise this has previously been shown for the Rockefeller strain . However, total mortality occurred later in populations exposed to DD. Empirical observations during CSI bioassays indicate that in many cases, a small number of larvae remain alive for long periods, regardless of the dosage. However, these larvae never progress to adulthood. Probably, this occurs due to natural variations among specimens of field populations.
The absence of adult emergence when field populations are exposed to triflumuron, repudiates cross-resistance between this CSI and neurotoxic inseticides. However, a positive correlation between pupal mortality rates and the temephos resistance ratios was noted, suggesting a potential triflumuron tolerance in populations resistant to this OP. This triflumuron tolerance could derive from the increased activity of enzymes related to metabolic resistance, already detected in several Brazilian Ae. aegypti populations [10, 34]. In contrast, correlation between deltamethrin mortality rates and triflumuron induced pupae mortality in these Ae. aegypti populations were not detected. This result may in part be associated with the qualitative nature of the PY bioassay, consisting of a single dose. Although there are few reports concerning IGR resistance, diflubenzuron tolerance associated with mixed-function oxidases was evidenced in blowflies . In mosquitoes however, to date IGR resistance has not yet been directly associated with increased activity of detoxifying enzymes.
Our results indicate that triflumuron was effective against the three mosquito species evaluated. Furthermore, this CSI was also potent against seven Ae. aegypti populations resistant to the two major classes of insecticides currently adopted in vector control. IGRs generally offer low toxicity to mammals, including man. Therefore, triflumuron might be considered an alternative for mosquito control in urban areas, although it has not yet been approved for application in drinking water, which precludes its use against Ae. aegypti.
This work was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (Faperj), Fundação Oswaldo Cruz (FIOCRUZ, PAPES and PDTSP programmes) The authors are grateful to BayerCropscience for the triflumuron samples. English review and revision by Mitchell Raymond Lishon, native of Chicago Illinois, U.S.A. – U.C.L.A. 1969. We dedicate this paper to the memory of Alexandre A. Peixoto, an outstanding friend and scientist.
- Juliano SA, Lounibos LP: Ecology of invasive mosquitoes: effects on resident species and on human health. Ecol Letters. 2005, 8: 558-574. 10.1111/j.1461-0248.2005.00755.x.View Article
- Ottesen EA, Ramachandran CP: Lymphatic filariasis infection and disease: control strategies. Parasitol Today. 1995, 11: 129-131. 10.1016/0169-4758(95)80128-6.View Article
- Gardner CL, Ryman KD: Yellow Fever: A Reemerging Threat. Clin Lab Med. 2010, 30: 237-260. 10.1016/j.cll.2010.01.001.PubMed CentralView ArticlePubMed
- Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martínez E, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW: Dengue: a continuing global threat. Nat Rev Microbiol. 2010, 8: S7-S16. 10.1038/nrmicro2460.PubMed CentralView ArticlePubMed
- Blitvich BJ: Transmission dynamics and changing epidemiology of West Nile virus. Anim Health Res Rev. 2008, 9: 71-86. 10.1017/S1466252307001430.View ArticlePubMed
- Ching Ng L, Hapuarachchi HC: Tracing the path of chikungunya virus- evolution and adaptation. Infect Genet Evol. 2010, 10: 876-885. 10.1016/j.meegid.2010.07.012.View Article
- Dibo MR, Menezes RMT, Ghirardelli CP, Mendonça AL, Neto FC: The presence of culicidae species in medium-sized cities in the state of São Paulo, Brazil and the risk of West Nile fever and other arbovirus infection. Rev Soc Bras Med Trop. 2011, 44: 496-503. 10.1590/S0037-86822011000400019.View ArticlePubMed
- Liu H, Cupp EW, Guo A, Liu N: Insecticide resistance in Alabama and Florida mosquito strains of Aedes albopictus. J Med Entomol. 2004, 41: 946-952. 10.1603/0022-2585-41.5.946.View ArticlePubMed
- Da-Cunha MP, Lima JBP, Brogdon WG, Moya GE, Valle D: Monitoring of resistance to the pyrethroid cypermetrin in Brazilian Aedes aegypti (Diptera: Culicidae) populations collected between 2001 and 2003. Mem Inst Oswaldo Cruz. 2005, 100: 441-444. 10.1590/S0074-02762005000400017.View ArticlePubMed
- Montella IR, Martins-Jr AJ, Viana-Medeiros PF, Lima JBP, Braga IA, Valle D: Insecticide resistance mechanisms of Brazilian Aedes aegypti populations from 2001 to 2004. AmJTrop Med Hyg. 2007, 77: 467-477.
- Martins AJ, Lima JBP, Peixoto AA, Valle D: Frequency of Val1016Ile mutation in the voltage-gated sodium channel gene of Aedes aegypti Brazilian populations. Trop Med Int Health. 2009, 14: 1351-1355. 10.1111/j.1365-3156.2009.02378.x.View ArticlePubMed
- Graf JF: The role of insect growth regulators in arthropod control. Parasitol Today. 1993, 9: 471-474. 10.1016/0169-4758(93)90106-P.View ArticlePubMed
- Zaim M, Guillet P: Alternative insecticides: an urgent need. Trends Parasitol. 2002, 18: 161-163. 10.1016/S1471-4922(01)02220-6.View ArticlePubMed
- Mian LS, Mulla MS: Biological and environmental dynamics of insect growth regulators (IGRs) as used against Diptera of public health importance. Residue Rev. 1982, 84: 27-112.View ArticlePubMed
- Reynolds SE: The cuticle, growth and moulting in insects: the essential background to the action of acylurea insecticides. Pest Science. 1987, 20: 131-146. 10.1002/ps.2780200207.View Article
- Tunaz H, Uygun N: Insect growth regulators for insect pest control. Turk J Agric For. 2004, 28: 377-387.
- Fontoura NG, Bellinato DF, Valle D, Lima JBP: The efficacy of a chitin synthesis inhibitor against field populations of organophosphate-resistant Aedes aegypti in Brazil. Mem Inst Oswaldo Cruz. 2012, 107: 387-395. 10.1590/S0074-02762012000300014.View ArticlePubMed
- Mulla MS, Thavara U, Tawatsin A, Chompoosri J, Zaim M, Su T: Laboratory and field evaluation of novaluron, a new acylurea insect growth regulator, against Aedes aegypti (Diptera: Culicidae). J Vector Ecol. 2003, 28: 241-254.PubMed
- Ansari MA, Razdan RK, Sreehari U: Laboratory and field evaluation of himilin against mosquitoes. J Am Mosq Control Assoc. 2005, 21: 432-436. 10.2987/8756-971X(2006)21[432:LAFEOH]2.0.CO;2.View ArticlePubMed
- Martins AJ, Belinato TA, Lima JBP, Valle D: Chitin synthesis inhibitor effect on Aedes aegypti populations susceptible and resistant to the organophosphate temephos. Pest Manag Sci. 2008, 64: 676-680. 10.1002/ps.1547.View ArticlePubMed
- Farnesi LC, Brito JM, Linss JG, Pelajo-Machado M, Valle D, Rezende GL: Physiological and morphological aspects of Aedes aegypti developing larvae: effects of the chitin synthesis inhibitor novaluron. PLoS One. 2012, 7: e30363-10.1371/journal.pone.0030363.PubMed CentralView ArticlePubMed
- Wilson TG, Cryan JR: Lufenuron, a chitin-synthesis inhibitor, interrupts development of Drosophila melanogaster. J Exp Zool. 1997, 278: 37-44. 10.1002/(SICI)1097-010X(19970501)278:1<37::AID-JEZ4>3.0.CO;2-7.View ArticlePubMed
- Vasuki V: Adult longevity of certain mosquito species after larval and pupal exposure to sublethal concentration of an insect growth regulator hexaflumuron. Southeast Asian J Trop Med Public Health. 1992, 23: 121-124.PubMed
- Vasuki V: The effects of sublethal doses of hexaflumuron on the feeding behavior of mosquitoes (Diptera: Culicidae). Bull Entomol Res. 1992, 82: 535-538. 10.1017/S0007485300042632.View Article
- Vasuki V: Influence of IGR treatment on oviposition of three species of vector mosquitoes at sublethal concentrations. Southeast Asian J Trop Med Public Health. 1999, 30: 200-203.PubMed
- Belinato TA, Martins AJ, Lima JBP, Lima-Camara TN, Peixoto AA, Valle D: Effect of the chitin synthesis inhibitor triflumuron on the development, viability and the reproduction of Aedes aegypti. Mem Inst Oswaldo Cruz. 2009, 104: 43-47. 10.1590/S0074-02762009000100007.View ArticlePubMed
- Suman DS, Parashar BD, Prakash S: Effect of sublethal dose of diflubenzuron and azadirachtin on various life table attributes of Culex quinquefasciatus (Diptera: Culicidae). J Med Entomol. 2010, 47: 996-1002. 10.1603/ME09190.View ArticlePubMed
- Kuno G: Early history of laboratory breeding of Aedes aegypti (Diptera:Culicidae) focusing on the origins and use of selected strains. J Med Entomol. 2010, 47: 957-971. 10.1603/ME10152.View ArticlePubMed
- World Health Organization: Instructions for determining the susceptibility or resistance of mosquito larvae to insecticides (WHO/VBC/1981). 1981, Geneva: WHO
- Raymond M: Presentation d’une programme d’analyse logprobit pour microordinateur cahiers Orstrom. Sér Ent Med Parasitol. 1985, 22: 117-121.
- Ministério da Saúde: Reunião técnica para discutir status de resistência de Aedes aegypti a inseticidas. Rio de Janeiro/Brazil: Coordenação Geral do Programa Nacional do Controle da Dengue, Relatório final, unpublished document, 27-29/2006 March, Rio de Janeiro/RJ
- Davidson G, Zahar AR: The practical implications of resistance of malaria vectors to insecticides. Bull WHO. 1973, 49: 475-483.PubMed CentralPubMed
- Boudjelida H, Bouaziz A, Soin T, Smagghe G, Soltani N: Effects of ecdysone agonist halofenozide against Culex pipiens. Pestic Biochem Physiol. 2005, 83: 115-123.View Article
- Braga IA, Mello CB, Peixoto AA, Valle D: Evaluation of methoprene effect on Aedes aegypti (Diptera: Culicidae) development in laboratory conditions. Mem Inst Oswaldo Cruz. 2005, 100: 435-440. 10.1590/S0074-02762005000400016.View ArticlePubMed
- Su T, Mulla MS, Zaim M: Laboratory and field evaluations of novaluron, a new insect growth regulator (IGR), against Culex mosquitoes. J Am Mosq Control Assoc. 2033, 19: 408-418.
- Bayer CropScience. [http://www.bayersaudeanimal.com.br/html/pdf/bula/peixes/STARYCIDE_SC_480_BULA.pdf]
- Mulla MS, Darwazeh HA: New insect growth regulators against flood and stagnant water mosquito - Effects on non target organisms. Mosq News. 1979, 39: 746-
- Mulla MS: The future of insect growth regulators in vector control. J Am Mosq Control Assoc. 1995, 11: 269-273.PubMed
- Ali A, Nayar JK, Rui-de X: Comparative toxicity of selected larvicides and insect growth regulators to a Florida laboratory population of Aedes albopictus. J Am Mosq Control Assoc. 1995, 36: 72-76.
- Montada D, Rajavel AR, Vasuki V: Use of hexaflumuron, an insect growth regulator in the control of Aedes albopictus (Skuse). Southeast Asian J Trop Med Public Health. 1994, 25: 374-377.PubMed
- Sulaiman S, Jeffery J, Sohadi RA: Residual efficacy of triflumuron against the dengue vector, Aedes albopictus (Skuse). Bull Soc Vector Ecol. 1994, 1994 (19): 111-114.
- Batra CP, Mittal PK, Adak T, Ansari MA: Efficacy of IGR compound Starycide 480 SC (Triflumuron) against mosquito larvae in clear and polluted water. J Vect Borne Dis. 2005, 42: 109-116.
- Kotze AC, Sales N, Barchia IM: Diflubenzuron tolerance associated with monooxygenase activity in field strain larvae of the Australian sheep blowfly (Diptera: Calliphoridae). J Econ Entomol. 1997, 90: 15-20.View ArticlePubMed
- World Health Organization: Dengue: Guidelines for diagnosis, treatment, prevention and control. 1999, Geneva: WHO
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.